AstraZeneca-Daiichi breast cancer treatment shows promise in latest study
An experimental breast cancer drug being developed by British drugmaker AstraZeneca and Japan's Daiichi Sankyo's met its main goal in a mid-stage study, bolstering their position in a highly competitive oncology market.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: AstraZeneca | Breast Cancer | Cancer | Cancer & Oncology | Health | Japan Health | Study | UK Health